The number of obese children has quadrupled since 1990 prompting the WHO to take action by issuing treatment guidelines.

A five-nanobody antivenom protected mice from lethal cobra and king cobra venom, offering a potential new approach to treating snakebites in India.

Continued progress against cancer will require collaboration among all key stakeholders. To this end, more stable and sustained federal investment is essential.

Given what some experts and clinicians cite as a lack of clear evidentiary benefit, FDA approval doesn’t guarantee reimbursement of multi-cancer early detection tests.

A rare inherited EGFR mutation raises lung cancer odds 25-fold overall and more than 60-fold in never-smokers, revealing why some nonsmokers develop lung cancer.

With Medicare Advantage premiums to drop by 16% in 2027, this could further boost the percentage of seniors and disabled folks who choose the privately run alternative.

A test of 511 AI-designed antibodies shows AI can improve promising drug candidates, but lab experiments remain essential for discovering safe, developable antibodies.

While Pharmacy First could partially relieve wait times at GP offices and emergency rooms, it’s sidestepping the larger chronic problem of NHS underfunding.

The question becomes whether firms will respond by withdrawing drugs from certain markets or delaying launches of their newly approved drugs in these jurisdictions.

The question becomes whether firms will respond by withdrawing drugs from certain markets or delaying launches of their newly approved drugs in these jurisdictions.